Its pharmacological effects stem primarily from the disruption of monoaminergic neurotransmission and its downstream neurotoxic consequences
Sodium, potassium, and magnesium support normal function and prevent symptoms that might be mistaken for peptide side effects
May support improved tissue function by reducing the senescence-associated secretory phenotype (SASP)
Research shows BPC-157 treatment accelerates healing of transected tendons through promotion of tendon outgrowth, cell survival, and cell migration via regulation of ERK1/2 phosphorylation and downstream targets including c-Fos, c-Jun, and Egr-1key molecules involved in cell growth, migration, and angiogenesis
It is not approved for human or animal use, and may not be used in food, drugs, cosmetics, or diagnostic applications